Concepedia

Publication | Closed Access

Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)

241

Citations

35

References

2010

Year

Abstract

Rifaximin significantly improves both cognitive functions and HRQOL in patients with MHE.

References

YearCitations

Page 1